Sunday Nov 24
Effects of combination lipid therapy in type 2 diabetes mellitus.
The New England journal of medicine , Vol. 362, No. 17. , pp. 1563-1574, doi:10.1056/nejmoa1001282 We investigated whether combination therapy with a statin plus a fibrate, as compared with statin monotherapy, would reduce the risk of cardiovascular disease in patients with type 2 diabetes mellitus who were at high risk for cardiovascular disease.
Researchers from Military Hospital Report Details of New Studies and...
In the present study, the liquid nanostructured lipid carriers , which were comprised of Precirol ATO 5, Captexl 00, Tween-80 and fenofibrate as the model drug, was prepared by the melting-emulsification method and converted to solidified NLC pellets by fluid-bed coating technique."
Safety and efficacy of long-term combination therapy with bezafibrate ...
There are numerous reports describing the efficacy of fenofibrate in combination with ezetimibe for treating dyslipidemia.
The Motley Fool
Amarin Gets a Nail in Its Already-Dead Drug Approval Coffin
I'm not surprised the FDA would pull the SPA. It was painfully obvious that the agency had changed its view on whether lowering triglycerides improves cardiovascular outcomes since it established the agreement with Amarin in 2009.